Who we are
We are a privately owned Biotechnology company in the Republic of South Africa located in the City of Johannesburg, the technological hub and business innovation centre of South Africa.
BGM recognises the need for the development of new therapies as well as improvement of existing therapies. BGM is committed to investing significantly into various research programmes that will empower future generation.
MARTIN S. MAGWAZA
President & Managing Director
Martin is the co-founder and President of BGM. Prior to the founding of BGM , he held numerous commercial roles with increasing responsibility in many top multinationals in South Africa. He has managed product portfolios including Anti-Infectives, Cardio-Metabolic, Heamatology, Neuroscience, Oncology, Transplant Medicine.
He received undergraduate training in Microbiology & Biochemistry at University of Natal, Postgraduate training in GIS at Nelson Mandela Metropolitan University, and completed a MBA at the Gordon Institute of Science, University of Pretoria in South Africa
MARK G. BLOY
Vice President & Business Development
Mark is the co-founder and Director of BGM. He was a teacher by profession, after decades of teaching the youth of South Africa he decided to pursue a career in the healthcare business.
Mark founded a diversified Healthcare company in 2001 , with a primary focus in the construction and commisioning of specialised Dialysis units across Africa.
Mark brings with him a wealth of experience in doing business in Africa through partnerships with Multinational companies, Government and NGOs.